600201 生物股份
已收盘 07-17 15:00:00
资讯
新帖
简况
股市必读：新发布《致同会计师事务所（特殊普通合伙）关于辽宁成大生物股份有限公司2025年年报问询函的回复》
证券之星 · 07-13
股市必读：新发布《致同会计师事务所（特殊普通合伙）关于辽宁成大生物股份有限公司2025年年报问询函的回复》
每周股票复盘：生物股份（600201）半年度净利预增50.60%至80.39%
证券之星 · 07-12
每周股票复盘：生物股份（600201）半年度净利预增50.60%至80.39%
生物股份：预计2026年1-6月扣非后净利润盈利7000万元至9100万元
证券之星 · 07-05
生物股份：预计2026年1-6月扣非后净利润盈利7000万元至9100万元
生物股份最新公告：预计2026年半年度净利润同比增长50.60%-80.39%
证券之星 · 07-05
生物股份最新公告：预计2026年半年度净利润同比增长50.60%-80.39%
生物股份：本次临床试验方案中未包含重组毒株数据
证券之星 · 07-02
生物股份：本次临床试验方案中未包含重组毒株数据
生物股份：本次试验攻毒后的观察期为28天
证券之星 · 07-02
生物股份：本次试验攻毒后的观察期为28天
生物股份(600201.SH)拟5000万元认购晨曦浩然核心2号私募证券投资基金
智通财经 · 07-01
生物股份(600201.SH)拟5000万元认购晨曦浩然核心2号私募证券投资基金
每周股票复盘：生物股份（600201）首次回购115万股耗资1318万
证券之星 · 06-28
每周股票复盘：生物股份（600201）首次回购115万股耗资1318万
生物股份（600201）披露以集中竞价交易方式首次回购公司股份的公告，6月26日股价下跌5.3%
证券之星 · 06-26
生物股份（600201）披露以集中竞价交易方式首次回购公司股份的公告，6月26日股价下跌5.3%
6月26日生物股份跌5.30%，养殖ETF国泰基金重仓该股
证券之星 · 06-26
6月26日生物股份跌5.30%，养殖ETF国泰基金重仓该股
股市必读：生物股份（600201）6月24日董秘有最新回复
证券之星 · 06-25
股市必读：生物股份（600201）6月24日董秘有最新回复
每周股票复盘：生物股份（600201）调整回购价格上限至20.70元
证券之星 · 06-20
每周股票复盘：生物股份（600201）调整回购价格上限至20.70元
【新股IPO】上海君赛生物股份有限公司向港交所主板递交上市申请
金吾财讯 · 06-16
【新股IPO】上海君赛生物股份有限公司向港交所主板递交上市申请
生物股份（600201）披露2025年年度权益分派实施后调整回购股份价格上限的公告，6月16日股价下跌0.8%
证券之星 · 06-16
生物股份（600201）披露2025年年度权益分派实施后调整回购股份价格上限的公告，6月16日股价下跌0.8%
每周股票复盘：生物股份（600201）生物控股质押208万股补充质押
证券之星 · 06-07
每周股票复盘：生物股份（600201）生物控股质押208万股补充质押
金宇生物技术宣布计划回购价值2亿至4亿元A股股份（更正公司名称及股票代码）
美股速递 · 06-05
金宇生物技术宣布计划回购价值2亿至4亿元A股股份（更正公司名称及股票代码）
生物股份(600201.SH)拟2亿元至4亿元回购股份
智通财经 · 06-05
生物股份(600201.SH)拟2亿元至4亿元回购股份
生物股份最新公告：董事长提议回购公司股份2亿元至4亿元
证券之星 · 06-03
生物股份最新公告：董事长提议回购公司股份2亿元至4亿元
股市必读：生物股份（600201）今年截至6月2日累计跌幅已超25%
证券之星 · 06-03
股市必读：生物股份（600201）今年截至6月2日累计跌幅已超25%
生物股份（600201）披露股东股份质押公告，6月1日股价上涨1.03%
证券之星 · 06-01
生物股份（600201）披露股东股份质押公告，6月1日股价上涨1.03%
暂无数据
公司概况
公司名称：
金宇生物技术股份有限公司
所属行业：
医药制造业
上市日期：
1999-01-15
主营业务：
金宇生物技术股份有限公司的主营业务是兽用生物制品的研发、生产与销售。公司的主要产品是猪用疫苗、反刍动物疫苗、禽用疫苗、宠物类疫苗。
发行价格：
6.83
{"stockData":{"symbol":"600201","market":"SH","secType":"STK","nameCN":"生物股份","latestPrice":11.58,"timestamp":1784271600000,"preClose":12.02,"halted":0,"volume":21078404,"delay":0,"changeRate":-0.0366,"floatShares":1112000000,"shares":1112000000,"eps":0.0938,"marketStatus":"已收盘","change":-0.44,"latestTime":"07-17 15:00:00","open":11.99,"high":12.03,"low":11.48,"amount":247000000,"amplitude":0.0458,"askPrice":11.59,"askSize":20,"bidPrice":11.58,"bidSize":112,"shortable":0,"etf":0,"ttmEps":0.0938,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1784511000000},"marketStatusCode":5,"adr":0,"adjPreClose":12.02,"symbolType":"stock","openAndCloseTimeList":[[1784251800000,1784259000000],[1784264400000,1784271600000]],"highLimit":13.22,"lowLimit":10.82,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1111747826,"isCdr":false,"pbRate":2.36,"roa":"--","peRate":123.454158,"roe":"1.49%","epsLYR":0.09,"committee":0.765766,"marketValue":12874000000,"turnoverRate":0.019,"status":1,"floatMarketCap":12874000000},"requestUrl":"/m/hq/s/600201/tweets","defaultTab":"tweets","newsList":[{"id":"2651166204","title":"股市必读：新发布《致同会计师事务所（特殊普通合伙）关于辽宁成大生物股份有限公司2025年年报问询函的回复》","url":"https://stock-news.laohu8.com/highlight/detail?id=2651166204","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2651166204?lang=zh_cn&edition=full","pubTime":"2026-07-13 03:17","pubTimestamp":1783883829,"startTime":"0","endTime":"0","summary":"致同会计师事务所关于辽宁成大生物股份有限公司2025年年报问询函的回复公司2025年实现营业收入13.9亿元，同比下降17.06%；境外收入同比增长23.37%；乙脑灭活疫苗收入下滑38.57%；研发投入4.22亿元，资本化比例30.39%；对联营企业成都史纪计提长期股权投资减值1,174.04万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071300001626.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0196","BK0028","BK0185","BK0012","BK0250","BK0188","BK0144","BK0239","600739","BK0074","600201","BK0046"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650154324","title":"每周股票复盘：生物股份（600201）半年度净利预增50.60%至80.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2650154324","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2650154324?lang=zh_cn&edition=full","pubTime":"2026-07-12 02:03","pubTimestamp":1783792990,"startTime":"0","endTime":"0","summary":"截至2026年7月10日收盘，生物股份报收于12.18元，较上周的12.31元下跌1.06%。本周，生物股份7月6日盘中最高价报12.99元。本周关注点公司公告汇总：生物股份预计2026年上半年净利同比增长50.60%至80.39%。公司公告汇总生物股份2026年半年度业绩预增公告金宇生物技术股份有限公司预计2026年半年度归属于上市公司股东的净利润为9,100万元到10,900万元，同比增长50.60%到80.39%；扣除非经常性损益后的净利润为7,000万元到9,100万元，同比增长117.45%到182.69%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071200000562.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600201","BK0239","BK0012","BK0188","BK0077","BK0028","BK0185","BK0046","BK0196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649361867","title":"生物股份：预计2026年1-6月扣非后净利润盈利7000万元至9100万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2649361867","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2649361867?lang=zh_cn&edition=full","pubTime":"2026-07-05 16:00","pubTimestamp":1783238426,"startTime":"0","endTime":"0","summary":"证券之星消息，生物股份发布业绩预告，预计2026年1-6月扣非后净利润盈利7000万元至9100万元。生物股份2026年一季报显示，一季度公司主营收入3.46亿元，同比下降1.45%；归母净利润8064.3万元，同比上升5.44%；扣非净利润6448.63万元，同比上升9.27%；负债率14.88%，投资收益-44.98万元，财务费用-1095.69万元，毛利率53.48%。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070500003645.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600201"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649618683","title":"生物股份最新公告：预计2026年半年度净利润同比增长50.60%-80.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2649618683","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2649618683?lang=zh_cn&edition=full","pubTime":"2026-07-05 15:50","pubTimestamp":1783237842,"startTime":"0","endTime":"0","summary":"生物股份(600201.SH)公告称，预计2026年半年度归属于上市公司股东的净利润为9100万元-10900万元，同比增长50.60%-80.39%。业绩变动主要系反刍和宠物动保业务大幅增长，产业并购协同价值显现，以及数字化、精益化管理推动费用和成本优化，新产品上市等多重因素驱动。注：公司Q2净利润预计0.1亿-0.28亿，Q1净利润0.81亿，据此计算，Q2净利润预计环比变动-87%--64%。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。相关 ETF","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070500003141.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600201"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648570461","title":"生物股份：本次临床试验方案中未包含重组毒株数据","url":"https://stock-news.laohu8.com/highlight/detail?id=2648570461","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2648570461?lang=zh_cn&edition=full","pubTime":"2026-07-02 16:15","pubTimestamp":1782980118,"startTime":"0","endTime":"0","summary":"证券之星消息，生物股份(600201)07月02日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘您好，公司在交流中提到疫苗靶点与当前流行重组毒株同源性达99.7%。请问在临床试验申报资料中，是否已经包含了针对目前主流基因重组毒株的实际交叉攻毒保护率数据？该部分数据是否已经提交给农业农村部审评？”生物股份回复：您好，本次临床试验方案中未包含重组毒株数据。在实验室研究阶段，该疫苗对当前流行毒株具有良好的交叉保护作用。感谢您的关注。本文数据来源于上海证券交易所e互动，仅供参考不构成投资建议。相关 ETF责任编辑：刘浩然","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070200026010.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0077","BK0012","BK0188","BK0046","BK0185","600201","BK0239","BK0196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648570414","title":"生物股份：本次试验攻毒后的观察期为28天","url":"https://stock-news.laohu8.com/highlight/detail?id=2648570414","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2648570414?lang=zh_cn&edition=full","pubTime":"2026-07-02 16:15","pubTimestamp":1782980113,"startTime":"0","endTime":"0","summary":"证券之星消息，生物股份(600201)07月02日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘您好!公司非瘟亚单位疫苗攻毒试验的观察周期为多少天？是否有针对更长免疫持续期（覆盖生猪完整生长周期）的具体验证数据？田间试验是否包含了不同阶段的猪只以验证长效防护能力？”生物股份回复：您好，本次试验攻毒后的观察期为28天。猪只在二次免疫后的4个月进行第二次免疫持续期攻毒测试，通常该阶段的猪只已经具备出栏条件，疫苗二次免疫可保护完整的生长周期。感谢您的关注。本文数据来源于上海证券交易所e互动，仅供参考不构成投资建议。相关 ETF责任编辑：刘浩然","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070200025998.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0046","BK0185","600201","BK0188","BK0196","BK0012","BK0239","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648130005","title":"生物股份(600201.SH)拟5000万元认购晨曦浩然核心2号私募证券投资基金","url":"https://stock-news.laohu8.com/highlight/detail?id=2648130005","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2648130005?lang=zh_cn&edition=full","pubTime":"2026-07-01 16:05","pubTimestamp":1782893118,"startTime":"0","endTime":"0","summary":"智通财经APP讯，生物股份(600201.SH)发布公告，为提高公司的资金使用效率，增加公司收益，在不影响正常生产经营、有效控制风险的前提下，公司全资子公司金宇保灵生物药品有限公司(以下简称“金宇保灵”)与晨曦(深圳)私募证券投资基金管理有限公司(以下简称“晨曦投资”)及国泰海通证券股份有限公司(以下简称“国泰海通”)于近日共同签订了《晨曦浩然核心2号私募证券投资基金私募基金合同》，公司拟使用自有资金5000万元人民币认购晨曦浩然核心2号私募证券投资基金。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1461844.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0188","600201","BK0077","BK0028","BK0185","161027","BK0012","BK0239","BK0046","BK0196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646313362","title":"每周股票复盘：生物股份（600201）首次回购115万股耗资1318万","url":"https://stock-news.laohu8.com/highlight/detail?id=2646313362","media":"证券之星","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2646313362?lang=zh_cn&edition=full","pubTime":"2026-06-28 01:59","pubTimestamp":1782583147,"startTime":"0","endTime":"0","summary":"截至2026年6月26日收盘，生物股份报收于11.44元，较上周的11.77元下跌2.8%。本周，生物股份6月24日盘中最高价报12.5元。本周关注点公司公告汇总：生物股份首次回购1,150,000股，支付资金13,183,901.00元。本次回购基于2026年6月5日第十二届董事会第六次会议审议通过的回购方案，拟用于维护公司价值及股东权益，回购总金额预计为20,000万元至40,000万元，回购期限为董事会审议通过后3个月内。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062800000403.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0239","BK0188","BK0012","BK0077","600201","BK0196","BK0046","BK0185"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646637303","title":"生物股份（600201）披露以集中竞价交易方式首次回购公司股份的公告，6月26日股价下跌5.3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2646637303","media":"证券之星","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2646637303?lang=zh_cn&edition=full","pubTime":"2026-06-26 22:20","pubTimestamp":1782483630,"startTime":"0","endTime":"0","summary":"截至2026年6月26日收盘，生物股份报收于11.44元，较前一交易日下跌5.3%，最新总市值为127.18亿元。该股当日开盘12.0元，最高12.12元，最低11.41元，成交额达2.4亿元，换手率为1.85%。近日，生物股份发布《关于以集中竞价交易方式首次回购公司股份的公告》。本次回购是基于公司于2026年6月5日召开的第十二届董事会第六次会议审议通过的回购方案，拟用于维护公司价值及股东权益，回购总金额预计为20,000万元至40,000万元，回购期限为董事会审议通过后3个月内。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062600045581.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0028","BK0077","BK0012","600201","BK0188","BK0196","BK0239","BK0185"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646133089","title":"6月26日生物股份跌5.30%，养殖ETF国泰基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2646133089","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2646133089?lang=zh_cn&edition=full","pubTime":"2026-06-26 16:25","pubTimestamp":1782462312,"startTime":"0","endTime":"0","summary":"证券之星消息，6月26日生物股份跌5.30%，收盘报11.44元，换手率1.85%，成交量20.61万手，成交额2.4亿元。根据2026基金Q1季报公募基金重仓股数据，重仓该股的公募基金共17家，其中持有数量最多的公募基金为国泰基金的养殖ETF国泰。养殖ETF国泰目前规模为47.41亿元，最新净值0.478，较上一交易日下跌1.01%，近一年下跌19.77%。养殖ETF国泰的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062600029759.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0012","BK0185","159865","BK0028","BK0077","BK0188","BK0196","600201","BK0046"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646281817","title":"股市必读：生物股份（600201）6月24日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2646281817","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2646281817?lang=zh_cn&edition=full","pubTime":"2026-06-25 01:20","pubTimestamp":1782321617,"startTime":"0","endTime":"0","summary":"截至2026年6月24日收盘，生物股份报收于12.29元，上涨3.45%，换手率2.41%，成交量26.84万手，成交额3.29亿元。公司公告汇总：生物股份披露回购报告书，拟以2亿至4亿元自有资金及专项贷款回购股份，价格上限20.70元/股，期限不超过3个月，回购用途为维护公司价值及股东权益。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062500001223.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0196","BK0188","BK0046","BK0012","BK0239","600201","BK0028","BK0185","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644063990","title":"每周股票复盘：生物股份（600201）调整回购价格上限至20.70元","url":"https://stock-news.laohu8.com/highlight/detail?id=2644063990","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2644063990?lang=zh_cn&edition=full","pubTime":"2026-06-20 02:05","pubTimestamp":1781892313,"startTime":"0","endTime":"0","summary":"截至2026年6月18日收盘，生物股份报收于11.77元，较上周的12.28元下跌4.15%。本周，生物股份6月16日盘中最高价报12.54元。本周关注点公司公告汇总：生物股份因权益分派调整回购股份价格上限至不超过20.70元/股。生物股份发布关于2025年年度权益分派实施后调整回购股份价格上限的公告，因每10股派发现金红利0.37元（含税），将回购股份价格上限由不超过20.74元/股调整为不超过20.70元/股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062000000532.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600201","BK0185","BK0028","BK0196","BK0012","BK0188","BK0239","BK0046","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643765752","title":"【新股IPO】上海君赛生物股份有限公司向港交所主板递交上市申请","url":"https://stock-news.laohu8.com/highlight/detail?id=2643765752","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2643765752?lang=zh_cn&edition=full","pubTime":"2026-06-16 23:06","pubTimestamp":1781622369,"startTime":"0","endTime":"0","summary":"金吾财讯 | 据港交所2026年6月16日文件，上海君赛生物股份有限公司向港交所主板递交上市申请，独家保荐人为中信证券。公司此次为第二次递表，目前未在其他资本市场上市。股权方面，金博士、易女士及多家关联主体构成上市后单一最大股东集团，企业过往已完成七轮融资，凯泰资本、复容投资为主要投资方。本次募资拟用于 GC101、GC203 等多款候选产品的临床开发，同时投入技术平台升级、产能建设及补充营运资金。","market":"nz","thumbnail":"https://static.szfiu.com/news/20220324/NjMyZjUxNTAyODM5OTc0.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20220324/NjMyZjUxNTAyODM5OTc0.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1983946","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0185","BK0028","600201","BK0196","BK0012","HEXmain","IPOS","BK0046","BK0077","BK0239","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643533677","title":"生物股份（600201）披露2025年年度权益分派实施后调整回购股份价格上限的公告，6月16日股价下跌0.8%","url":"https://stock-news.laohu8.com/highlight/detail?id=2643533677","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2643533677?lang=zh_cn&edition=full","pubTime":"2026-06-16 17:44","pubTimestamp":1781603068,"startTime":"0","endTime":"0","summary":"截至2026年6月16日收盘，生物股份报收于12.38元，较前一交易日下跌0.8%，最新总市值为137.63亿元。近日，生物股份发布《关于2025年年度权益分派实施后调整回购股份价格上限的公告》。公告显示，公司因实施2025年年度权益分派，向全体股东每10股派发现金红利0.37元（含税），根据相关规定及回购股份预案，对公司回购股份价格上限进行相应调整。本次调整仅涉及回购价格上限，其他回购事项未发生变化。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061600032031.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0185","BK0188","BK0077","BK0012","600201","BK0028","BK0196","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641122401","title":"每周股票复盘：生物股份（600201）生物控股质押208万股补充质押","url":"https://stock-news.laohu8.com/highlight/detail?id=2641122401","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2641122401?lang=zh_cn&edition=full","pubTime":"2026-06-07 01:37","pubTimestamp":1780767429,"startTime":"0","endTime":"0","summary":"截至2026年6月5日收盘，生物股份报收于11.29元，较上周的11.67元下跌3.26%。本周，生物股份6月2日盘中最高价报12.17元。公司公告汇总生物股份关于股东股份质押的公告内蒙古金宇生物控股有限公司持有金宇生物技术股份有限公司股份125,510,800股，占公司总股本的11.29%。本次质押2,080,000股无限售流通股给浙商证券股份有限公司，为补充质押，占其所持股份比例1.66%，占公司总股本比例0.19%。本次质押后，生物控股累计质押公司股份数量为20,350,000股，占其持股总数的16.21%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060700000334.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0196","BK0188","BK0046","BK0012","BK0239","600201","BK0028","BK0185","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1146238127","title":"金宇生物技术宣布计划回购价值2亿至4亿元A股股份（更正公司名称及股票代码）","url":"https://stock-news.laohu8.com/highlight/detail?id=1146238127","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1146238127?lang=zh_cn&edition=full","pubTime":"2026-06-05 17:41","pubTimestamp":1780652477,"startTime":"0","endTime":"0","summary":"金宇生物技术股份有限公司宣布，计划实施一项A股股份回购计划，回购资金总额预计在人民币2亿元至4亿元之间。此举旨在优化公司资本结构，并基于对未来持续发展的信心以及对公司内在价值的认可。\n公司表示，本次回购的股份将用于后续的员工持股计划或股权激励，以进一步完善公司的长效激励机制，充分调动核心团队的积极性，促进公司的长期稳定发展。具体的回购价格、实施期限等细节将根据市场情况，在回购期限内择机实施。\n此次股份回购计划需提交公司股东大会审议，并将在获得相关批准后正式启动。公司强调，本次回购不会对公司的经营、财务及未来发展产生重大不利影响。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0188","BK0012","BK0046","BK0239","BK0185","BK0077","BK0028","600201","BK0196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641011927","title":"生物股份(600201.SH)拟2亿元至4亿元回购股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2641011927","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2641011927?lang=zh_cn&edition=full","pubTime":"2026-06-05 17:36","pubTimestamp":1780652177,"startTime":"0","endTime":"0","summary":"智通财经APP讯，生物股份(600201.SH)发布公告，公司拟2亿元至4亿元回购股份，回购价格不超过20.74元/股，将用于维护公司价值及股东权益。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1450757.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["600201","BK0077","BK0239","BK0046","BK0188","BK0196","BK0012","BK0028","BK0185"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640903071","title":"生物股份最新公告：董事长提议回购公司股份2亿元至4亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2640903071","media":"证券之星","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640903071?lang=zh_cn&edition=full","pubTime":"2026-06-03 18:19","pubTimestamp":1780481988,"startTime":"0","endTime":"0","summary":"生物股份(600201.SH)公告称，公司董事长张翀宇提议公司通过集中竞价交易方式回购部分公司股份，回购资金总额为2亿元至4亿元，回购的股份将用于维护公司价值及股东权益。回购价格上限不高于董事会审议通过回购方案决议前30个交易日公司股票交易均价的150%，回购期限为自董事会审议通过回购方案之日起3个月内。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060300037674.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0188","BK0185","BK0196","BK0046","600201","BK0239","BK0077","BK0012"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640940873","title":"股市必读：生物股份（600201）今年截至6月2日累计跌幅已超25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2640940873","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640940873?lang=zh_cn&edition=full","pubTime":"2026-06-03 02:01","pubTimestamp":1780423279,"startTime":"0","endTime":"0","summary":"当日关注点来自交易信息汇总：生物股份股价已连续11日下跌，年内累计跌幅达26.06%。公司公告汇总内蒙古金宇生物控股有限公司持有金宇生物技术股份有限公司股份125,510,800股，占公司总股本的11.29%。本次质押2,080,000股无限售流通股给浙商证券股份有限公司，为补充质押，占其所持股份比例1.66%，占公司总股本比例0.19%。本次质押后，生物控股累计质押公司股份数量为20,350,000股，占其持股总数的16.21%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060300002121.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0046","600201","BK0012","BK0185","BK0188","BK0028","BK0196","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640958873","title":"生物股份（600201）披露股东股份质押公告，6月1日股价上涨1.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2640958873","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640958873?lang=zh_cn&edition=full","pubTime":"2026-06-01 17:52","pubTimestamp":1780307528,"startTime":"0","endTime":"0","summary":"截至2026年6月1日收盘，生物股份报收于11.79元，较前一交易日上涨1.03%，最新总市值为131.08亿元。公告显示，内蒙古金宇生物控股有限公司持有金宇生物技术股份有限公司股份125,510,800股，占公司总股本的11.29%。本次质押2,080,000股无限售流通股给浙商证券股份有限公司，为补充质押，占其所持股份比例1.66%，占公司总股本比例0.19%。本次质押后，生物控股累计质押公司股份数量为20,350,000股，占其持股总数的16.21%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060100027976.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0185","BK0239","BK0196","600201","BK0012","BK0188","BK0046","BK0028","BK0077"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1784297219592,"stockEarnings":[{"period":"1week","weight":-0.0131},{"period":"1month","weight":-0.0261},{"period":"3month","weight":-0.1787},{"period":"6month","weight":-0.3153},{"period":"1year","weight":0.3923},{"period":"ytd","weight":-0.1999}],"compareEarnings":[{"period":"1week","weight":-0.0382},{"period":"1month","weight":-0.0512},{"period":"3month","weight":-0.0417},{"period":"6month","weight":-0.0535},{"period":"1year","weight":0.1081},{"period":"ytd","weight":-0.0218}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"金宇生物技术股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"44780人(较上一季度增加3.41%)","perCapita":"24826股","listingDate":"1999-01-15","address":"内蒙古自治区呼和浩特市土默特左旗经济技术开发区沙尔沁工业园区金宇大街1号","registeredCapital":"111174万元","survey":" 金宇生物技术股份有限公司的主营业务是兽用生物制品的研发、生产与销售。公司的主要产品是猪用疫苗、反刍动物疫苗、禽用疫苗、宠物类疫苗。","listedPrice":6.83},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"生物股份(600201)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供生物股份(600201)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"生物股份,600201,生物股份股票,生物股份股票老虎,生物股份股票老虎国际,生物股份行情,生物股份股票行情,生物股份股价,生物股份股市,生物股份股票价格,生物股份股票交易,生物股份股票购买,生物股份股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"生物股份(600201)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供生物股份(600201)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}